Logo En IconLogo Mark IconIcelandic Intellectual Property Office
Plus Black IconMortgagePlus Black IconLicensePlus Black IconRevocationPlus Black IconReissuePlus Black IconCorrected translationPlus Black IconSPCPlus Black IconÁrgjöld

EP4526683

AÐFERÐ TIL AÐ AUÐKENNA KRABBAMEINSSJÚKLINGA SEM HAGNAST AF ANTI-SNJALLT-1

  • Status:
    EP einkaleyfi í gildi á Íslandi
  • EP appl. date:
    19.5.2023
  • EP published:
    3.12.2025
  • EP application number:
    23726545.9
  • Max expiry date:
    18.5.2043
  • Expiry date:
    18.5.2026
  • Title in English:
    METHOD FOR IDENTIFYING CANCER PATIENTS THAT BENEFIT FROM ANTI-CLEVER-1 TREATMENT
  • Language of the patent:
    English

Timeline

Today
19.5.2023EP application
3.12.2025EP Publication
9.3.2026Translation submitted
8.4.2026Registration published
18.5.2026Expires

Owner

  • Name:
    Faron Pharmaceuticals OY
  • Address:
    Joukahaisenkatu 6, 20520 Turku, FI

Inventor

  • Name:
    JALKANEN, Juho
  • Address:
    23120 Mietoinen, FI
  • Name:
    BJÖRKMAN, Mari
  • Address:
    20720 Turku, FI
  • Name:
    HOLLMÉN, Maija-Leena
  • Address:
    20760 Piispanristi, FI

Agent

  • Name:
    G.H. Sigurgeirsson ehf.
  • Address:
    Borgartúni 26, 105, Reykjavík,

Priority

  • Number:
    20225445
  • Date:
    20.5.2022
  • Country:
    FI
  • Number:
    20225962
  • Date:
    26.10.2022
  • Country:
    FI

Classification

  • Categories:
    G01N 33/574

Upload documents